A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
A phase 2 trial of Ziv-aflibercept, Irinotecan and Fluorouracil in Colorectal cancer, run by Sanofi, completed.
Overview
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan is a phase 2 interventional study registered as NCT01882868 by Sanofi, with 62 participants recorded, started 2013-07 and reaching its primary completion in 2015-08. Interventions recorded: Aflibercept, Levofolinate, Irinotecan, 5-FU. Conditions recorded: Colorectal Cancer Metastatic.
Linked to the drug Ziv-aflibercept because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCombination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialFUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialPrevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma
Shares Ziv-aflibercept and the tag pipeline.
- TrialA Clinical Study of Arfolitixorin in Patients With mCRC
Shares Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialHigh-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28
Shares Irinotecan (and liposomal irinotecan), Colorectal cancer and the tag pipeline.
- TrialTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialPalliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Shares Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.